Literature DB >> 28797776

Increase in seizure susceptibility in sepsis like condition explained by spiking cytokines and altered adhesion molecules level with impaired blood brain barrier integrity in experimental model of rats treated with lipopolysaccharides.

Rakesh K Sewal1, Manish Modi1, Uma Nahar Saikia1, Amitava Chakrabarti1, Bikash Medhi2.   

Abstract

BACKGROUND AND
OBJECTIVE: Epilepsy is a neurological disorder characterized by recurrent unprovoked seizures. Sepsis is a condition which initiates a cascade of a surge of inflammatory mediators. Interplay between seizures and inflammation other than of brain origin is yet to be explored. The present study was designed to evaluate the seizure susceptibility in experimental models of lipopolysaccharide (LPS) induced sepsis. DESIGN AND METHODS: Experimental sepsis was induced using lipopolysaccharides in Wistar rats. Valproic acid, dexametasone were given to two different groups of animals along with LPS. Two groups of animals were subjected to administration of vehicle and LPS respectively with no other treatment. 24h later, animals were subjected to seizures by using either maximal electro shock or pentylenetetrazole. Seizures related parameters, oxidative stress and TNF-α, IL-6, IL-1β, ICAM-1, ICAM-2, VCAM-1, MMP-9 level in serum and brain samples were evaluated. Histopathological and blood brain barrier permeability studies were conducted.
RESULTS: Seizures were decreased in valproic acid treated animals. Reduced oxidative stress was seen in dexamethasone plus valproic acid treated groups as compared to LPS alone treated group. TNF-α, IL-6, IL-1β, ICAM-1, VCAM-1, MMP-9 levels were found increased in LPS treated animals whereas a reverse observation was noted for ICAM-2 level in brain and serum. Histopathological findings confirmed the successful establishment of sepsis like state in animals. Blood brain barrier permeability was found increased in LPS treated groups of animals.
CONCLUSION: Seizure susceptibility may escalate during the sepsis like inflammatory conditions and curbing the inflammatory state might reverse the phenomenon.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Adhesion molecules; Blood brain barrier; Cytokines; Lipopolysaccharides; Seizure; Sepsis

Mesh:

Substances:

Year:  2017        PMID: 28797776     DOI: 10.1016/j.eplepsyres.2017.05.012

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  Exploring blood-brain barrier hyperpermeability and potential biomarkers in traumatic brain injury.

Authors:  Bobby Darnell Robinson; Binu Tharakan; Angela Lomas; Katie Wiggins-Dohlvik; Himakarnika Alluri; Chinchusha Anasooya Shaji; Daniel Jupiter; Claire Larson Isbell
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-04-02

Review 2.  A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.

Authors:  Shokufeh Ghasemian Sorboni; Hanieh Shakeri Moghaddam; Reza Jafarzadeh-Esfehani; Saman Soleimanpour
Journal:  Clin Microbiol Rev       Date:  2022-01-05       Impact factor: 26.132

Review 3.  Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain.

Authors:  Hao-Ming Xu; Hong-Li Huang; You-Lian Zhou; Hai-Lan Zhao; Jing Xu; Di-Wen Shou; Yan-Di Liu; Yong-Jian Zhou; Yu-Qiang Nie
Journal:  Gastroenterol Res Pract       Date:  2021-01-16       Impact factor: 2.260

4.  Celecoxib Decrease Seizures Susceptibility in a Rat Model of Inflammation by Inhibiting HMGB1 Translocation.

Authors:  Hadeel Alsaegh; Hala Eweis; Fatemah Kamal; Aziza Alrafiah
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-19

5.  Screening of prototype antiseizure and anti-inflammatory compounds in the Theiler's murine encephalomyelitis virus model of epilepsy.

Authors:  Cameron S Metcalf; Fabiola Vanegas; Tristan Underwood; Kristina Johnson; Peter J West; Misty D Smith; Karen S Wilcox
Journal:  Epilepsia Open       Date:  2021-11-03

Review 6.  Fecal Microbiota Transplantation in Neurological Disorders.

Authors:  Karuna E W Vendrik; Rogier E Ooijevaar; Pieter R C de Jong; Jon D Laman; Bob W van Oosten; Jacobus J van Hilten; Quinten R Ducarmon; Josbert J Keller; Eduard J Kuijper; Maria Fiorella Contarino
Journal:  Front Cell Infect Microbiol       Date:  2020-03-24       Impact factor: 5.293

Review 7.  Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale.

Authors:  Jing You; Haiyan Huang; Clement T Y Chan; Lin Li
Journal:  Front Neurol       Date:  2022-01-07       Impact factor: 4.003

8.  Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation.

Authors:  Chunxiang Jiang; Aysegul Caskurlu; Thota Ganesh; Ray Dingledine
Journal:  Brain Behav Immun Health       Date:  2020-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.